510(k) K142156
K142156 is an FDA 510(k) premarket notification submitted by Seegene for the device "SEEGENE ANYPLEX II HSV-1/2 ASSAY". The FDA issued a decision of Substantially Equivalent on Feb 13, 2015. The device falls under product code OQO (Herpes Simplex Virus Nucleic Acid Amplification Assay), a Class II device regulated under 21 CFR 866.3305.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Feb 13, 2015
- Date Received
- Aug 6, 2014
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Herpes Simplex Virus Nucleic Acid Amplification Assay
- Device Class
- Class II
- Regulation Number
- 866.3305
- Review Panel
- MI
- Submission Type
- 510(k)
A polymerase chain reaction (pcr)-based qualitative in vitro diagnostic test for the detection and typing of herpes simplex virus (hsv) dna using vaginal swab specimens.
Need the full FDA record for Seegene? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.